Breast cancer
Results
Phase 2
This trial looked at rucaparib for people with triple negative breast cancer (TNBC) or breast cancer with a .
Triple negative breast cancer means it does not have receptors for the hormones oestrogen or progesterone, or for the protein HER2.
This trial was supported by Cancer Research UK. People could join between 2015 and 2017. The team published the results in 2020.
Recruitment start: 1 August 2015
Recruitment end: 30 August 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nicholas Turner
Cancer Research UK
Clovis Oncology Inc
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
NIHR Clinical Research Network: Cancer
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK number CRUK/12/034.
Last reviewed: 11 Mar 2026
CRUK internal database number: 10083
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
